View More View Less
  • 1 Krankenhaus Barmherzige Brüder, Regensburg, Németország
  • | 2 Petz Aladár Megyei Oktató Kórház, Győr
  • | 3 Pécsi Tudományegyetem, Általános Orvostudományi Kar, Pécs
Restricted access

Absztrakt

A chylothorax napjainkban rendszerint műtéti vagy baleseti szövődmény, ritkábban daganat következménye. Prospektív vagy randomizált vizsgálatok hiányában a bizonyítékalapú kezelés személyes tapasztalaton, ideálisan a retrospektív elemzések ismeretében történik. A szerzők célja a chylothorax modern kezelésének áttekintése. A PubMed adatbázist „chylothorax” kulcsszóra szűrték az elmúlt tíz év közleményei között, kiemelve az összehasonlító értékeléseket. A módszerek és ajánlások kritikai elemzésekor a szerzők együttes 39 éves klinikai tapasztalatukra támaszkodtak. A konzervatív kezelés sikere az etiológiától függően nagy szórást mutat (3–90%). A non- és szemi-invazív intervenciós eljárások sikerrátája 50–100% közötti. Eredménytelen konzervatív kezeléskor a sebészi kezelés, elsősorban a ductus thoracicus lekötése jelenti a standard terápiát. Ezen beavatkozások sikerességi aránya 64–100% közötti, a morbiditási/mortalitási mutató elérheti a 25%-ot. A kezelést konzervatívan kell megkezdeni, majd egy lépcsőzetes agresszivitású terápia ajánlott, amelyben a beteg állapota és a drénvolumen irányítják a döntéshozatalt. Az intervenciós radiológiai eljárások biztonságosak, sikeresek és helyet kaptak a konzervatív és műtéti megoldások mellett. Orv. Hetil., 2016, 157(2), 43–51.

  • 1

    McGrath, E. E., Blades, Z., Anderson, P. B.: Chylothorax: aetiology, diagnosis and therapeutic options. Respir. Med., 2010, 104(1), 1–8.

  • 2

    Doerr, C. H., Allen, M. S., Nichols, F. C. 3rd, et al.: Etiology of chylothorax in 203 patients. Mayo Clin. Proc., 2005, 80(7), 867–870.

  • 3

    Narayan, P., Rahaman, N., Molnar, T. F., et al.: Chylothorax following cardiac surgery caused by unusual lymphatic anatomy. Asian Cardiovasc. Thorac. Ann., 2007, 15(5), e58–e59.

  • 4

    Sziklavari, Z., Allgäuer, M., Hübner, G., et al.: Radiotherapy in the treatment of postoperative chylothorax. J. Cardiothorac. Surg., 2013, 8, 72.

  • 5

    Chalret du Rieu, M., Baulieux, J., Rode, A., et al.: Management of postoperative chylothorax. J. Visc. Surg., 2011, 148(5), e346–e352.

  • 6

    Kaul, T. K., Bain, W. H., Turner, M. A., et al.: Chylothorax: report of a case complicating ductus ligation through a median sternotomy, and review. Thorax, 1976, 31(5), 610–616.

  • 7

    Phang, K., Bowman, M., Phillips, A., et al.: Review of thoracic duct anatomical variations and clinical implications. Clin. Anat., 2014, 27(4), 637–644.

  • 8

    Takuwa, T., Yoshida, J., Ono, S., et al.: Low-fat diet management strategy for chylothorax after pulmonary resection and lymph node dissection for primary lung cancer. J. Thorac. Cardiovasc. Surg., 2013, 146(3), 571–574.

  • 9

    Chen, E., Itkin, M.: Thoracic duct embolization for chylous leaks. Semin. Intervent. Radiol., 2011, 28(1), 63–74.

  • 10

    Lyon, S., Mott, N., Koukounaras, J., et al.: Role of interventional radiology in the management of chylothorax: a review of the current management of high output chylothorax. Cardiovasc. Intervent. Radiol., 2013, 36(3), 599–607.

  • 11

    Bryant, A. S., Minnich, D. J., Wei, B., et al.: The incidence and management of postoperative chylothorax after pulmonary resection and thoracic mediastinal lymph node dissection. Ann. Thorac. Surg., 2014, 98(1), 232–235.

  • 12

    Kunitoh, H., Kato, H., Tsuboi, M., et al.: Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806. J. Clin. Oncol., 2008, 26(4), 644–649.

  • 13

    Light, R. W.: Pleural effusions. Med. Clin. North Am., 2011, 95(6), 1055–1070.

  • 14

    Rustico, M. A., Lanna, M., Coviello, D., et al.: Fetal pleural effusion. Prenat. Diagn., 2007, 27(9), 793–799.

  • 15

    Yekeler, E., Ulutas, H.: Bilateral chylothorax after severe vomiting in a child. Ann. Thorac. Surg., 2012, 94(1), e21–e23.

  • 16

    Miller, J. I. Jr.: Anatomy of the thoracic duct and chylothorax. In: Shields, T. W., LoCicero, J. 3rd, Ponn, R. B., et al. (eds.): General thoracic surgery. 6th ed. Lippincott Williams & Wilkins, Philadelphia, 2005, 879–888.

  • 17

    Staats, B. A., Ellefson, R. D., Budahn, L. L., et al.: The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin. Proc., 1980, 55(11), 700–704.

  • 18

    Maldonado, F., Hawkins, F. J., Daniels, C. E., et al.: Pleural fluid characteristics of chylothorax. Mayo Clin. Proc., 2009, 84(2), 129–133.

  • 19

    Sassoon, C. S., Light, R. W.: Chylothorax and pseudochylothorax. Clin. Chest Med., 1985, 6(1), 163–171.

  • 20

    Skouras, V., Kalomenidis, I.: Chylothorax: diagnostic approach. Curr. Opin. Pulm. Med., 2010, 16(4), 387–393.

  • 21

    Huggins, J. T.: Chylothorax and cholesterol pleural effusion. Semin. Respir. Crit. Care Med., 2010, 31(6), 743–750.

  • 22

    Benedix, F., Lippert, H., Meyer, F.: Etiology, diagnosis and treatment of lymphocutaneous fistulas, chylascites and chylothorax as infrequent but serious complications following surgical procedures. Zentralbl. Chir., 2012, 137(6), 580–586.

  • 23

    Sziklavari, Z., Neu, R., Hofmann, H. S., et al.: Persistent pleural effusion following thoracic surgery. Chirurg, 2015, 86(5), 432–436.

  • 24

    Wasmuth-Pietzuch, A., Hansmann, M., Bartmann, P., et al.: Congenital chylothorax: lymphopenia and high risk of neonatal infections. Acta Paediatr., 2004, 93(2), 220–224.

  • 25

    Breaux, J., Marks, C.: Chylothorax causing reversible T-cell depletion. J. Trauma, 1988, 28(5), 705–707.

  • 26

    Hölscher, A. H., Fetzner, U. K., Bludau, M., et al.: Complications and management of complications in oesophageal surgery. Zentralbl. Chir., 2011, 136(3), 213–223.

  • 27

    Shah, R. D., Luketich, J. D., Schuchert, M. J., et al.: Postesophagectomy chylothorax: Incidence, risk factors, and outcomes. Ann. Thorac. Surg., 2012, 93(3), 897–904.

  • 28

    Bessone, L. N., Ferguson, T. B., Burford, T. H.: Chylothorax. Ann. Thorac. Surg., 1971, 12(5), 527–550.

  • 29

    Guo, W., Zhao, Y. P., Jiang, Y. G., et al.: Prevention of postoperative chylothorax with thoracic duct ligation during video-assisted thoracoscopic esophagectomy for cancer. Surg. Endosc., 2012, 26(5), 1332–1336.

  • 30

    Nair, S. K., Petko, M., Hayward, M. P.: Aetiology and management of chylothorax in adults. Eur. J. Cardiothorac. Surg., 2007, 32(2), 362–369.

  • 31

    DePew, Z. S., Iqbal, S., Mullon, J. J., et al.: The role for tunneled indwelling pleural catheters in patients with persistent benign chylothorax. Am. J. Med. Sci., 2013, 346(5), 349–352.

  • 32

    Zabeck, H., Muley, T., Dienemann, H., et al.: Management of chylothorax in adults: when is surgery indicated? Thorac. Cardiovasc. Surg., 2011, 59(4), 243–246.

  • 33

    Cerfolio, R. J., Allen, M. S., Deschamps, C., et al.: Postoperative chylothorax. J. Thorac. Cariovasc. Surg., 1996, 112(5), 1361–1365.

  • 34

    Shimizu, K., Yoshida, J., Nishimura, M., et al.: Treatment strategy for chylothorax after pulmonary resection and lymph node dissection for lung cancer. J. Thorac. Cardiovasc. Surg., 2002, 124(3), 499–502.

  • 35

    Fujita, T., Daiko, H.: Efficacy and predictor of octreotide treatment for postoperative chylothorax after thoracic esophagectomy. World J. Surg., 2014, 38(8), 2039–2045.

  • 36

    Cho, H. J., Kim, D. K., Lee, G. D., et al.: Chylothorax complicating pulmonary resection for lung cancer: effective management and pleurodesis. Ann. Thorac. Surg., 2014, 97(2), 408–413.

  • 37

    Maldonado, F., Cartin-Ceba, R., Hawkins, F. J., et al.: Medical and surgical management of chylothorax and associated outcomes. Am. J. Med. Sci., 2010, 339(4), 314–318.

  • 38

    Das, A., Shah, P. S.: Octreotide for the treatment of chylothorax in neonates. Cochrane Database Syst. Rev., 2010, 8(9), CD006388.

  • 39

    Bello, S. O., Rahamim, J.: High-dose intravenous octreotide is safe and may be superior to surgery in managing severe postesophagectomy chylothorax in high-risk patients. Ann. Thorac. Surg., 2015, 100(1), 297–299.

  • 40

    Cannizzaro, V., Frey, B., Bernet-Buettiker, V.: The role of somatostatin in the treatment of persistent chylothorax in children. Eur. J. Cardiothorac. Surg., 2006, 30(1), 49–53.

  • 41

    Roehr, C. C., Jung, A., Proquitté, H., et al.: Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review. Intensive Care Med., 2006, 32(5), 650–657.

  • 42

    Sharkey, A. J., Rao, J. N.: The successful use of octreotide in the treatment of traumatic chylothorax. Tex. Heart Inst. J., 2012, 39(3), 428–430.

  • 43

    Lim, K. A., Kim, S. H., Huh, J., et al.: Somatostatin for postoperative chylothorax after surgery for children with congenital heart disease. J. Korean Med. Sci., 2005, 20(6), 947–951.

  • 44

    O’Callaghan, A. M., Mead, G. M.: Chylothorax in lymphoma: mechanisms and management. Ann. Oncol., 1995, 6(6), 603–607.

  • 45

    Teng, C. L., Li, K. W., Yu, J. T., et al.: Malignancy-associated chylothorax: a 20-year study of 18 patients from a single institution. Eur. J. Cancer Care, 2012, 21(5), 599–605.

  • 46

    Larsen, S., Manoharan, A., Fermanis, G., et al.: An unusual case of chylothorax complicating non-Hodgkin’s lymphoma. Leuk. Lymphoma, 2000, 38(1–2), 207–209.

  • 47

    Dietl, B., Pfister, K., Aufschläger, C., et al.: Radiotherapy of inguinal lymphorrhea after vascular surgery. A retrospective analysis. Strahlenther. Onkol., 2005, 181(6), 396–400.

  • 48

    Gómez-Caro, A. A., Moradiellos Diez, F. J., Marrón, C. F., et al.: Conservative management of postsurgical chylothorax with octreotide. Asian Cardiovasc. Thorac. Ann., 2005, 13(3), 222–224.

  • 49

    Collard, J. M., Laterre, P. F., Boemer, F., et al.: Conservative treatment of postsurgical lymphatic leaks with somatostatin-14. Chest, 2000, 117(3), 902–905.

  • 50

    Pui, M. H., Yueh, T. C.: Lymphoscintigraphy in chyluria, chyloperitoneum and chylothorax. J. Nucl. Med., 1998, 39(7), 1292–1296.

  • 51

    Yu, D. X., Ma, X. X., Wang, Q., et al.: Morphological changes of the thoracic duct and accessory lymphatic channels in patients with chylothorax: detection with unenhanced magnetic resonance imaging. Eur. Radiol., 2013, 23(3), 702–711.

  • 52

    Lutz, P., Strunk, H., Schild, H. H., et al.: Transjugular intrahepatic portosystemic shunt in refractory chylothorax due to liver cirrhosis. World J. Gastroenterol., 2013, 19(7), 1140–1142.

  • 53

    Itkin, M., Kucharczuk, J. C., Kwak, A., et al.: Nonoperative thoracic duct embolization for traumatic thoracic duct leak: experience in 109 patients. J. Thorac. Cardiovasc. Surg., 2010, 139(3), 584–589.

  • 54

    Akin, H., Olcmen, A., Isgorucu, O., et al.: Approach to patients with chylothorax complicating pulmonary resection. Thorac. Cardiovasc. Surg., 2012, 60(2), 135–139.

  • 55

    Paul, S., Altorki, N. K., Port, J. L., et al.: Surgical management of chylothorax. Thorac. Cardiovasc. Surg., 2009, 57(4), 226–228.

  • 56

    Schoellnast, H., Maybody, M. Getrajdman, G. I., et al.: Computed tomography-guided access to the cisterna chyli: introduction of a technique for direct lymphangiography to evaluate and treat chylothorax. Cardiovasc. Intervent. Radiol., 2011, 34(Suppl. 2), S240–S244.

  • 57

    Alejandre-Lafont, E., Krompiec, C., Rau, W. S., et al.: Effectiveness of therapeutic lymphography on lymphatic leakage. Acta Radiol., 2011, 52(3), 305–311.

  • 58

    Cope, C., Salem, R., Kaiser, L. R.: Management of chylothorax by percutaneous catheterization and embolization of the thoracic duct: prospective trial. J. Vasc. Interv. Radiol., 1999, 10(9), 1248–1254.

  • 59

    Cope, C., Kaiser, L.: Management of unremitting chylothorax by percutaneous embolization and blockage of retroperitoneal lymphatic vessels in 42 patients. J. Vasc. Interv. Radiol., 2002, 13(11), 1139–1148.

  • 60

    Nadolski, G. J., Itkin, M.: Thoracic duct embolization for nontraumatic chylous effusion: experience in 34 patients. Chest, 2013, 143(1), 158–163.

  • 61

    Boffa, D. J., Sands, M. J., Rice, T. W., et al.: A critical evaluation of a percutaneous diagnostic and treatment strategy for chylothorax after thoracic surgery. Eur. J. Cardiothorac. Surg., 2008, 33(3), 435–439.

  • 62

    Lee, E. W., Shin, J. H., Ko, H. K., et al.: Lymphangiography to treat postoperative lymphatic leakage: a technical review. Korean J. Radiol., 2014, 15(6), 724–732.

  • 63

    Gaba, R. C., Owens, C. A., Bui, J. T., et al.: Chylous ascites: a rare complication of thoracic duct embolization for chylothorax. Cardiovasc. Intervent. Radiol., 2011, 34(2), 245–249.

  • 64

    Binkert, C. A., Yucel, K., Davison, B. D., et al.: Percutaneous treatment of high-output chylothorax with embolization or needle disruption technique. J. Vasc. Interv. Radiol., 2005, 16(9), 1257–1262.

  • 65

    Litherland, B., Given, M., Lyon, S.: Percutaneous radiological management of high output chylothorax with CT-guided needle disruption. J. Med. Imaging Radiat. Oncol., 2008, 52(2), 164–167.

  • 66

    Bölükbas, S., Kudelin, N., Dönges, T., et al.: Therapy management of chylothorax. Chirurg, 2010, 81(3), 255–263.

  • 67

    Laslett, D., Trerotola, S. C., Itkin, M.: Delayed complications following technically successful thoracic duct embolization. J. Vasc. Interv. Radiol., 2012, 23(1), 76–79.

  • 68

    Orringer, M. B., Bluett, M., Deeb, G. M.: Aggressive treatment of chylothorax complicating transhiatal esophagectomy without thoracotomy. Surgery, 1988, 104(4), 720–726.

  • 69

    Alexiou, C., Watson, M., Beggs, D., et al.: Chylothorax following oesophagogastrectomy for malignant disease. Eur. J. Cardiothorac. Surg., 1998, 14(5), 460–466.

  • 70

    Ryu, J. H., Tomassetti, S., Maldonado, F.: Update on uncommon pleural effusions. Respirology, 2011, 16(2), 238–243.

  • 71

    Sahn, S. A.: Management of malignant pleural effusions. Monaldi Arch. Chest Dis., 2001, 56(5), 394–399.

  • 72

    Gupta, D., Ross, K., Piacentino, V. 3rd, et al.: Use of LeVeen pleuroperitoneal shunt for refractory high-volume chylothorax. Ann. Thorac. Surg., 2004, 78(1), e9–e12.

  • 73

    Akaogi, E., Mitsui, K., Sohara, Y., et al.: Treatment of postoperative chylothorax with intrapleural fibrin glue. Ann. Thorac. Surg., 1989, 48(1), 116–118.

All Time Past Year Past 30 Days
Abstract Views 137 137 19
Full Text Views 25 11 0
PDF Downloads 35 22 0